Product Code: LI_17525 / A00423
Metabolomics is study and analysis of biochemical processes involving intermediates and products of metabolic activity. The products are called as metabolomes that reflect a cluster of all metabolites involved in a reaction within an organism which includes metabolic intermediates, signaling molecules, secondary metabolites, and hormones.
Metabolomics includes utilization of various analytical processes for determination of metabolites which include spectroscopy, chromatography, and multivariate analysis. Metabolites are closely related to the phenotype of an organism and can be used for wide range of applications such as substantial equivalence testing and phenotyping of genetically modified plants, identification of gene function, and biotic-abiotic stress reaction analysis. Furthermore, it also allows researchers and scientists to calculate physiological effects and observe the adverse reaction of drugs on an organism.
Increased adoption of metabolomics in precision medicine, continues technological advances in medical devices is expected to drive the metabolomics market. Moreover, increased private and government funding for metabolomics R&D is expected to propel the metabolomics market in the analysis period. However, the high cost of analytical and equipment and their maintenance, and lack of effective data management is expected to encumber the market growth.
The metabolomics market is segmented based on product & services, applications, indications, and geography. Based on product and service, it is divided into metabolomics instruments and metabolomics bioinformatics tools & services. Metabolomics instruments are further classified into separation tools (high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis) and detection technique (mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis). Metabolomics bioinformatics tools and services are further divided into bioinformatics tools & databases and bioinformatics services. Based on application, the market is categorized into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and other applications. Based on indications, it is divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other indications.
By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Product development and research collaborations are the key strategies adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global metabolomics market.
- The overall impact of COVID-19 on the metabolomics market was fairly positive. This was due to the fact that metabolomics was applied in research to study COVID-19 disease. For instance, metabolomics is used for analysis of volatile organic compounds exhaled by COVID-19 patients. Thus, this quality of metabolomics led to its applications in a large-scale screening of population in point-of-care (POC) setting. In addition, active research is also ongoing related to the discovery of potential metabolomics-based prognostic markers for COVID-19. Similarly, a number of metabolic pathways related to energy metabolism, amino acid, and lipids were found to be affected by severe disease with COVID-19.
- Hence, the rise in demand of metabolomics products for COVID-19 related research lead to a surge in growth of market which in turn impacted the market in a positive manner. KEY BENEFITS FOR STAKEHOLDERS
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the Metabolomics Market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
- By Product and Service
- Metabolomics Instruments
- Separation Techniques
- High Performance Liquid Chromatography
- Gas Chromatography
- Ultra Performance Liquid chromatography
- Capillary Electrophoresis
- Detection Technique
- Mass Spectrometry
- Nuclear Magnetic Resonance Spectrometry
- Surface Based Mass Analysis
- Metabolomics Bioinformatic Tools and services
- Bioinformatic Services
- Bioinformatics Tools and Database
- By Application
- Biomarkers Discovery
- Drug Discovery
- Nutrigenomics
- Toxivology Testing
- Functional Genomics
- Personalized Medicine
- Others
- By Indication
- Cancer
- Cardiovascular Disease
- Neurological Disorders
- Inborn Errors of Metabolism
- Other
- By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- #Agilent Technologies, Inc.
- #Danaher Corporation
- #Biocrates Life Sciences AG
- Bruker Corporation
- LECO Corporation
- Metabolon, Inc.
- Human Metabolome Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Shimadzu Corporation
- Waters Corporation
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report Description
- 1.2.Key Market Segments
- 1.3.Key Benefits
- 1.4.Research Methodology
- 1.4.1.Primary Research
- 1.4.2.Secondary Research
- 1.4.3.Analyst Tools and Models
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market Definition and Scope
- 3.2.Key Findings
- 3.2.1.Top Investment Pockets
- 3.2.2.Top Winning Strategies
- 3.3.Porter's Five Forces Analysis
- 3.3.1.Bargaining Power of Suppliers
- 3.3.2.Threat of New Entrants
- 3.3.3.Threat of Substitutes
- 3.3.4.Competitive Rivalry
- 3.3.5.Bargaining Power among Buyers
- 3.4.Market Share Analysis/Top Player Positioning
- 3.4.1. Market Share Analysis/Top Player Positioning 2020
- 3.5.Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities
- 3.6.COVID-19 Impact Analysis
CHAPTER 4:METABOLOMICS MARKET, BY PRODUCT AND SERVICES
- 4.1.Market Overview
- 4.1.1Market Size and Forecast, By Product And Services
- 4.2. Metabolomics Instruments
- 4.2.1.Key Market Trends, Growth Factors and Opportunities
- 4.2.2.Market Size and Forecast, By Region
- 4.2.3.Market Share Analysis, By Country
- 4.2.4.Separation Tools
- 4.2.4.1.Market Size and Forecast
- 4.2.5.2.High-Performance Liquid Chromatography
- 4.2.5.2.1.Market Size and Forecast
- 4.2.5.2.Gas Chromatography
- 4.2.5.2.1.Market Size and Forecast
- 4.2.5.2.Ultra Performance Liquid Chromatography
- 4.2.5.2.1.Market Size and Forecast
- 4.2.5.2.Capillary Electrophoresis
- 4.2.5.2.1.Market Size and Forecast
- 4.2.5.Detection Tools
- 4.2.5.1.Market Size and Forecast
- 4.2.6.2.Mass Spectrometry
- 4.2.6.2.1.Market Size and Forecast
- 4.2.6.2.Nuclear Magnetic Resonance Spectroscopy
- 4.2.6.2.1.Market Size and Forecast
- 4.2.6.2.Surface-Based Mass Analysis
- 4.2.6.2.1.Market Size and Forecast
- 4.3. Metabolomics Bioinformatics Tools And Services
- 4.3.1.Key Market Trends, Growth Factors and Opportunities
- 4.3.2.Market Size and Forecast, By Region
- 4.3.3.Market Share Analysis, By Country
- 4.3.4.Bioinformatics Tools
- 4.3.4.1.Market Size and Forecast
- 4.3.5.Databases and Bioinformatics Services
- 4.3.5.1.Market Size and Forecast
CHAPTER 5:METABOLOMICS MARKET, BY APPLICATION
- 5.1.Market Overview
- 5.1.1Market Size and Forecast, By Application
- 5.2. Biomarker Discovery
- 5.2.1.Key Market Trends, Growth Factors and Opportunities
- 5.2.2.Market Size and Forecast, By Region
- 5.2.3.Market Share Analysis, By Country
- 5.3. Drug Discovery
- 5.3.1.Key Market Trends, Growth Factors and Opportunities
- 5.3.2.Market Size and Forecast, By Region
- 5.3.3.Market Share Analysis, By Country
- 5.4. Toxicology Testing
- 5.4.1.Key Market Trends, Growth Factors and Opportunities
- 5.4.2.Market Size and Forecast, By Region
- 5.4.3.Market Share Analysis, By Country
- 5.5. Nutrigenomics
- 5.5.1.Key Market Trends, Growth Factors and Opportunities
- 5.5.2.Market Size and Forecast, By Region
- 5.5.3.Market Share Analysis, By Country
- 5.6. Functional Genomics
- 5.6.1.Key Market Trends, Growth Factors and Opportunities
- 5.6.2.Market Size and Forecast, By Region
- 5.6.3.Market Share Analysis, By Country
- 5.7. Personalized Medicine
- 5.7.1.Key Market Trends, Growth Factors and Opportunities
- 5.7.2.Market Size and Forecast, By Region
- 5.7.3.Market Share Analysis, By Country
- 5.8. Other Applications
- 5.8.1.Key Market Trends, Growth Factors and Opportunities
- 5.8.2.Market Size and Forecast, By Region
- 5.8.3.Market Share Analysis, By Country
CHAPTER 6:METABOLOMICS MARKET, BY INDICATION
- 6.1.Market Overview
- 6.1.1Market Size and Forecast, By Indication
- 6.2. Cancer
- 6.2.1.Key Market Trends, Growth Factors and Opportunities
- 6.2.2.Market Size and Forecast, By Region
- 6.2.3.Market Share Analysis, By Country
- 6.3. Cardiovascular Disorders
- 6.3.1.Key Market Trends, Growth Factors and Opportunities
- 6.3.2.Market Size and Forecast, By Region
- 6.3.3.Market Share Analysis, By Country
- 6.4. Neurological Disorders
- 6.4.1.Key Market Trends, Growth Factors and Opportunities
- 6.4.2.Market Size and Forecast, By Region
- 6.4.3.Market Share Analysis, By Country
- 6.5. Inborn Errors Of Metabolism
- 6.5.1.Key Market Trends, Growth Factors and Opportunities
- 6.5.2.Market Size and Forecast, By Region
- 6.5.3.Market Share Analysis, By Country
- 6.6. Other Indications
- 6.6.1.Key Market Trends, Growth Factors and Opportunities
- 6.6.2.Market Size and Forecast, By Region
- 6.6.3.Market Share Analysis, By Country
CHAPTER 7:METABOLOMICS MARKET, BY REGION
- 7.1.Market Overview
- 7.1.1Market Size and Forecast, By Region
- 7.2.North America
- 7.2.1.Key Market Trends and Opportunities
- 7.2.2.Market Size and Forecast, By Product And Services
- 7.2.3.Market Size and Forecast, By Application
- 7.2.4.Market Size and Forecast, By Indication
- 7.2.5.Market Size and Forecast, By Country
- 7.2.6.United States Metabolomics Market
- 7.2.6.1.Market Size and Forecast, By Product And Services
- 7.2.6.2.Market Size and Forecast, By Application
- 7.2.6.3.Market Size and Forecast, By Indication
- 7.2.7.Canada Metabolomics Market
- 7.2.7.1.Market Size and Forecast, By Product And Services
- 7.2.7.2.Market Size and Forecast, By Application
- 7.2.7.3.Market Size and Forecast, By Indication
- 7.2.8.Mexico Metabolomics Market
- 7.2.8.1.Market Size and Forecast, By Product And Services
- 7.2.8.2.Market Size and Forecast, By Application
- 7.2.8.3.Market Size and Forecast, By Indication
- 7.3.Europe
- 7.3.1.Key Market Trends and Opportunities
- 7.3.2.Market Size and Forecast, By Product And Services
- 7.3.3.Market Size and Forecast, By Application
- 7.3.4.Market Size and Forecast, By Indication
- 7.3.5.Market Size and Forecast, By Country
- 7.3.6.Germany Metabolomics Market
- 7.3.6.1.Market Size and Forecast, By Product And Services
- 7.3.6.2.Market Size and Forecast, By Application
- 7.3.6.3.Market Size and Forecast, By Indication
- 7.3.7.France Metabolomics Market
- 7.3.7.1.Market Size and Forecast, By Product And Services
- 7.3.7.2.Market Size and Forecast, By Application
- 7.3.7.3.Market Size and Forecast, By Indication
- 7.3.8.Uk Metabolomics Market
- 7.3.8.1.Market Size and Forecast, By Product And Services
- 7.3.8.2.Market Size and Forecast, By Application
- 7.3.8.3.Market Size and Forecast, By Indication
- 7.3.9.Italy Metabolomics Market
- 7.3.9.1.Market Size and Forecast, By Product And Services
- 7.3.9.2.Market Size and Forecast, By Application
- 7.3.9.3.Market Size and Forecast, By Indication
- 7.3.10.Spain Metabolomics Market
- 7.3.10.1.Market Size and Forecast, By Product And Services
- 7.3.10.2.Market Size and Forecast, By Application
- 7.3.10.3.Market Size and Forecast, By Indication
- 7.3.11.Rest Of Europe Metabolomics Market
- 7.3.11.1.Market Size and Forecast, By Product And Services
- 7.3.11.2.Market Size and Forecast, By Application
- 7.3.11.3.Market Size and Forecast, By Indication
- 7.4.Asia-Pacific
- 7.4.1.Key Market Trends and Opportunities
- 7.4.2.Market Size and Forecast, By Product And Services
- 7.4.3.Market Size and Forecast, By Application
- 7.4.4.Market Size and Forecast, By Indication
- 7.4.5.Market Size and Forecast, By Country
- 7.4.6.Japan Metabolomics Market
- 7.4.6.1.Market Size and Forecast, By Product And Services
- 7.4.6.2.Market Size and Forecast, By Application
- 7.4.6.3.Market Size and Forecast, By Indication
- 7.4.7.China Metabolomics Market
- 7.4.7.1.Market Size and Forecast, By Product And Services
- 7.4.7.2.Market Size and Forecast, By Application
- 7.4.7.3.Market Size and Forecast, By Indication
- 7.4.8.Australia Metabolomics Market
- 7.4.8.1.Market Size and Forecast, By Product And Services
- 7.4.8.2.Market Size and Forecast, By Application
- 7.4.8.3.Market Size and Forecast, By Indication
- 7.4.9.India Metabolomics Market
- 7.4.9.1.Market Size and Forecast, By Product And Services
- 7.4.9.2.Market Size and Forecast, By Application
- 7.4.9.3.Market Size and Forecast, By Indication
- 7.4.10.South Korea Metabolomics Market
- 7.4.10.1.Market Size and Forecast, By Product And Services
- 7.4.10.2.Market Size and Forecast, By Application
- 7.4.10.3.Market Size and Forecast, By Indication
- 7.4.11.Rest Of Asia-pacific Metabolomics Market
- 7.4.11.1.Market Size and Forecast, By Product And Services
- 7.4.11.2.Market Size and Forecast, By Application
- 7.4.11.3.Market Size and Forecast, By Indication
- 7.5.LAMEA
- 7.5.1.Key Market Trends and Opportunities
- 7.5.2.Market Size and Forecast, By Product And Services
- 7.5.3.Market Size and Forecast, By Application
- 7.5.4.Market Size and Forecast, By Indication
- 7.5.5.Market Size and Forecast, By Country
- 7.5.6.Brazil Metabolomics Market
- 7.5.6.1.Market Size and Forecast, By Product And Services
- 7.5.6.2.Market Size and Forecast, By Application
- 7.5.6.3.Market Size and Forecast, By Indication
- 7.5.7.Saudi Arabia Metabolomics Market
- 7.5.7.1.Market Size and Forecast, By Product And Services
- 7.5.7.2.Market Size and Forecast, By Application
- 7.5.7.3.Market Size and Forecast, By Indication
- 7.5.8.South Africa Metabolomics Market
- 7.5.8.1.Market Size and Forecast, By Product And Services
- 7.5.8.2.Market Size and Forecast, By Application
- 7.5.8.3.Market Size and Forecast, By Indication
- 7.5.9.Rest of LAMEA Metabolomics Market
- 7.5.9.1.Market Size and Forecast, By Product And Services
- 7.5.9.2.Market Size and Forecast, By Application
- 7.5.9.3.Market Size and Forecast, By Indication
CHAPTER 8:COMPANY PROFILES
- 8.1. Agilent Technologies, Inc.
- 8.1.1.Company Overview
- 8.1.2.Key Executives
- 8.1.3.Company snapshot
- 8.1.4.Operating business segments
- 8.1.5.Product portfolio
- 8.1.6.Business Performance
- 8.1.7.Key Strategic Moves and Developments
- 8.2. Danaher Corporation
- 8.2.1.Company Overview
- 8.2.2.Key Executives
- 8.2.3.Company snapshot
- 8.2.4.Operating business segments
- 8.2.5.Product portfolio
- 8.2.6.Business Performance
- 8.2.7.Key Strategic Moves and Developments
- 8.3. Biocrates Life Sciences AG
- 8.3.1.Company Overview
- 8.3.2.Key Executives
- 8.3.3.Company snapshot
- 8.3.4.Operating business segments
- 8.3.5.Product portfolio
- 8.3.6.Business Performance
- 8.3.7.Key Strategic Moves and Developments
- 8.4. Bruker Corporation
- 8.4.1.Company Overview
- 8.4.2.Key Executives
- 8.4.3.Company snapshot
- 8.4.4.Operating business segments
- 8.4.5.Product portfolio
- 8.4.6.Business Performance
- 8.4.7.Key Strategic Moves and Developments
- 8.5. LECO Corporation
- 8.5.1.Company Overview
- 8.5.2.Key Executives
- 8.5.3.Company snapshot
- 8.5.4.Operating business segments
- 8.5.5.Product portfolio
- 8.5.6.Business Performance
- 8.5.7.Key Strategic Moves and Developments
- 8.6. Metabolon, Inc.
- 8.6.1.Company Overview
- 8.6.2.Key Executives
- 8.6.3.Company snapshot
- 8.6.4.Operating business segments
- 8.6.5.Product portfolio
- 8.6.6.Business Performance
- 8.6.7.Key Strategic Moves and Developments
- 8.7. Human Metabolome Technologies, Inc.
- 8.7.1.Company Overview
- 8.7.2.Key Executives
- 8.7.3.Company snapshot
- 8.7.4.Operating business segments
- 8.7.5.Product portfolio
- 8.7.6.Business Performance
- 8.7.7.Key Strategic Moves and Developments
- 8.8. Bio-Rad Laboratories, Inc.
- 8.8.1.Company Overview
- 8.8.2.Key Executives
- 8.8.3.Company snapshot
- 8.8.4.Operating business segments
- 8.8.5.Product portfolio
- 8.8.6.Business Performance
- 8.8.7.Key Strategic Moves and Developments
- 8.9. Shimadzu Corporation
- 8.9.1.Company Overview
- 8.9.2.Key Executives
- 8.9.3.Company snapshot
- 8.9.4.Operating business segments
- 8.9.5.Product portfolio
- 8.9.6.Business Performance
- 8.9.7.Key Strategic Moves and Developments
- 8.10. Waters Corporation
- 8.10.1.Company Overview
- 8.10.2.Key Executives
- 8.10.3.Company snapshot
- 8.10.4.Operating business segments
- 8.10.5.Product portfolio
- 8.10.6.Business Performance
- 8.10.7.Key Strategic Moves and Developments